Genetic Technologies Stock Market Value
| GENE Stock | USD 0.77 0.00 0.00% |
| Symbol | Genetic |
Genetic Technologies Price To Book Ratio
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genetic Technologies. If investors know Genetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genetic Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 2.19 | Quarterly Revenue Growth (0.11) | Return On Assets (0.63) | Return On Equity (1.85) |
The market value of Genetic Technologies is measured differently than its book value, which is the value of Genetic that is recorded on the company's balance sheet. Investors also form their own opinion of Genetic Technologies' value that differs from its market value or its book value, called intrinsic value, which is Genetic Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genetic Technologies' market value can be influenced by many factors that don't directly affect Genetic Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genetic Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Genetic Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genetic Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Genetic Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genetic Technologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genetic Technologies.
| 08/28/2024 |
| 11/26/2024 |
If you would invest 0.00 in Genetic Technologies on August 28, 2024 and sell it all today you would earn a total of 0.00 from holding Genetic Technologies or generate 0.0% return on investment in Genetic Technologies over 90 days. Genetic Technologies is related to or competes with T2 Biosystms, Intelligent Bio, BioAffinity Technologies,, Agilent Technologies, Sera Prognostics, Precipio, and MDxHealth. Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment t... More
Genetic Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genetic Technologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genetic Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 8.88 | |||
| Value At Risk | (3.53) | |||
| Potential Upside | 3.33 |
Genetic Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genetic Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genetic Technologies' standard deviation. In reality, there are many statistical measures that can use Genetic Technologies historical prices to predict the future Genetic Technologies' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | 1.54 |
Genetic Technologies Backtested Returns
Genetic Technologies holds Efficiency (Sharpe) Ratio of -0.14, which attests that the entity had a -0.14% return per unit of risk over the last 3 months. Genetic Technologies exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genetic Technologies' Risk Adjusted Performance of (0.09), standard deviation of 1.74, and Market Risk Adjusted Performance of 1.55 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Genetic Technologies are expected to decrease at a much lower rate. During the bear market, Genetic Technologies is likely to outperform the market. At this point, Genetic Technologies has a negative expected return of -0.23%. Please make sure to check out Genetic Technologies' maximum drawdown, as well as the relationship between the skewness and day median price , to decide if Genetic Technologies performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.14 |
Insignificant reverse predictability
Genetic Technologies has insignificant reverse predictability. Overlapping area represents the amount of predictability between Genetic Technologies time series from 28th of August 2024 to 12th of October 2024 and 12th of October 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genetic Technologies price movement. The serial correlation of -0.14 indicates that less than 14.0% of current Genetic Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | -0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Genetic Technologies lagged returns against current returns
Autocorrelation, which is Genetic Technologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genetic Technologies' stock expected returns. We can calculate the autocorrelation of Genetic Technologies returns to help us make a trade decision. For example, suppose you find that Genetic Technologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Genetic Technologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genetic Technologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genetic Technologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genetic Technologies stock over time.
Current vs Lagged Prices |
| Timeline |
Genetic Technologies Lagged Returns
When evaluating Genetic Technologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genetic Technologies stock have on its future price. Genetic Technologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genetic Technologies autocorrelation shows the relationship between Genetic Technologies stock current value and its past values and can show if there is a momentum factor associated with investing in Genetic Technologies.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Genetic Technologies is a strong investment it is important to analyze Genetic Technologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Genetic Technologies' future performance. For an informed investment choice regarding Genetic Stock, refer to the following important reports:Check out Genetic Technologies Correlation, Genetic Technologies Volatility and Genetic Technologies Alpha and Beta module to complement your research on Genetic Technologies. For information on how to trade Genetic Stock refer to our How to Trade Genetic Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Genetic Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.